Heart · 2017 · 14 citations · 26 references
MedicineCardiologySurgeryCerebrovascular SurgeryInterventional CardiologyInterventional RadiologyAnticoagulation ManagementAtrial FibrillationLeft Atrial Appendage ClosureStrokeThrombosisThrombosis PreventionAnticoagulation AlternativesImplant Success CriteriaLeft Atrial Appendage ImagingLeft Atrial Appendage Occlusion DevicesLeft Atrial Appendage ThrombosisLeft Atrial Appendage ThrombusPercutaneous Left Atrial Appendage ClosureTherapeutic Anticoagulation
OBJECTIVE: Percutaneous left atrial appendage (LAA) occlusion can be an interventional alternative to oral anticoagulation for stroke prevention in patients with atrial fibrillation. METHODS: We delivered LAA occlusion therapy using a standardised approach to patient referral, multidisciplinary team assessment, implant criteria, imaging and follow-up. We analysed patient characteristics, efficacy and safety of the implant procedure, and 12-month outcomes. RESULTS: -VASc score 4 ±1) were offered LAA occlusion. Eighty (95.3%) had previous major bleeding (intracranial in 59%). LAA occluder implantation with an Amulet device was successful in 82 (98.8%), with periprocedural major adverse events occurring in 5 (6.0%) patients (2 device embolisations including 1 death, 2 major bleeds). Cardiac imaging in 75 (94%) patients 2months following implant showed device-related thrombus in 1 case (1.3%) and minor (<5mm) device leaks in 13 (17.1%). Over a median 12-month follow-up, 3 (3.8%) ischaemic strokes, 2 (2.5%) haemorrhagic strokes and 5 (6.3%) major extracranial bleeds occurred. All-cause mortality was 10%, with most deaths (7, 87.5%) due to non-cardiovascular causes. CONCLUSIONS: LAA occlusion may be a reasonable option for stroke prevention inhigh-risk patients with atrial fibrillation ineligible for anticoagulation. However, procedural complication rates are not insignificant, and patients remain at risk of serious adverse events and death even after successful implant.
26
Worldwide Epidemiology of Atrial Fibrillation
Sumeet S. Chugh, Rasmus Havmoeller, Kumar Narayanan et al. · Circulation · 2013 · 4.5K citations · Full text
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt et al. · Circulation · 2011 · 4.4K citations
Medicine, Cardiology, Hematology +10
David R. Holmes, Vivek Y. Reddy, Zoltan G. Turi et al. · The Lancet · 2009 · 2.2K citations